Schedule III Marijuana Would Still Be Regulated Marijuana
FDA Law Blog: Biosimilars
MARCH 24, 2025
In January a public hearing began to receive factual evidence and testimony on whether marijuana should be rescheduled. DEA published a Notice of Proposed Rulemaking (NPRM), signed by Attorney General Merrick Garland, proposing to reschedule marijuana in May 2024 that elicited over 43,500 comments.
Let's personalize your content